What this means
This review looks at many possible liver treatments, mostly tested in lab animals. It says human studies are still needed before anyone can know if they work.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- Animal models and earlier lab studies, as summarized in a narrative review
- Kind of research
- A summary of earlier studies
The science
- Original title
- Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review.
- Authors
- Sever M, Zenko Sever A, Klicek R et al.
- Journal
- Pharmaceuticals (Basel, Switzerland)
- Published
- Oct 27, 2026
- Study type
- Review
- PMID
- 42943255 ↗
Abstract
Cytoprotection provides a conceptual framework for the preservation and restoration of tissue integrity under conditions of noxious injury. In liver disease, however, effective protection may require more than direct limitation of hepatocellular damage, encompassing endothelial function, microcirculation, vascular homeostasis, oxidative stress, inflammation, fibrosis, and portal hemodynamics. This review examines possibilities for cytoprotective liver therapy, with particular emphasis on stable gastric pentadecapeptide BPC 157 and comparison with established or experimentally investigated agents, including N-acetylcysteine, ursodeoxycholic acid, corticosteroids, resveratrol, L-arginine, curcumin, sildenafil, VEGF-related approaches, stem cell therapies, melatonin, simvastatin, prostacyclin analogues, and coenzyme Q10. Evidence is considered across representative experimental models of acetaminophen and carbon tetrachloride hepatotoxicity, bile duct ligation, and alcohol-induced liver injury. The diversity of effective agents indicates that liver injury involves multiple interconnected pathological mechanisms and that preservation of hepatocellular integrity may be achieved through different pharmacological pathways. BPC 157 is distinguished by evidence of beneficial effects across these major models and additional vascular and occlusion/occlusion-like syndromes. In particular, reported findings indicate prevention and reversal of experimentally induced portal hypertension, including prehepatic, intrahepatic, and posthepatic disturbances, together with attenuation of hepatic congestion, thrombosis, oxidative injury, and associated multiorgan dysfunction. These findings support the concept that cytoprotection may extend from hepatoprotection to restoration of vascular and tissue homeostasis. Collectively, the available preclinical evidence supports further investigation of integrated cytoprotective strategies for liver injury. Nevertheless, experimental evidence, however extensive, does not establish clinical efficacy, and appropriately designed clinical studies remain necessary to determine therapeutic applicability in human liver disease.
Sever M, Zenko Sever A, Klicek R et al. Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review. Pharmaceuticals (Basel, Switzerland). 2026. doi:10.3390/ph19101559. PMID: 42943255. https://pubmed.ncbi.nlm.nih.gov/42943255/
Related research
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Neuronal receptor remodeling in the aging periosteum: From single-cell atlases to regenerative targets.
The periosteum is the most densely innervated compartment of the skeleton and harbors periosteal stem cells expressing a broad repertoire of neuronal receptors traditionally associated with the nervous system.
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
The Oxidative-Mitochondrial-Inflammatory Axis in Retinitis Pigmentosa: Extracellular mtDNA as Biomarker and Therapeutic Read-Out.
Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy (prevalence ~1:4000) and a leading Mendelian cause of working-age blindness.
Stem cells and exosomes studied for organ aging in animals
This is a review of 34 animal studies on stem cells and exosomes. It suggests these treatments may help aging organs, but the review does not show they work in people.
Fruit fly study finds a gene that helps remove aging gut cells
Researchers found a protein-making gene that rises in aging fruit fly gut cells and helps them get shed. This shows one possible way aging gut cells are cleared, but it is only a fruit fly finding.
See all research on BPC-157 peptide →